Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Eksp Onkol ; 7(1): 40-2, 1985.
Article in Russian | MEDLINE | ID: mdl-3920043

ABSTRACT

It is shown that in spite of the absence of the marked inhibition of the tumour growth in the preparative period listeria preparations decreased the percentage of recurrances. Based on the results obtained a conclusion is drawn that injection of listeria preparations into the tumour for several days before its surgical removal may be an effective prophylactic means of the relapse development.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Listeria monocytogenes , Neoplasm Recurrence, Local/prevention & control , Sarcoma 180/surgery , Animals , Drug Evaluation, Preclinical , Male , Mice , Neoplasm Transplantation , Postoperative Care , Preoperative Care , Time Factors
3.
J Pharmacobiodyn ; 6(2): 88-95, 1983 Feb.
Article in English | MEDLINE | ID: mdl-6683306

ABSTRACT

Augmentation of the host's immunity by combined in situ freeze-destruction of the tumor (cryosurgery) and administration of the antitumor active protein-bound polysaccharide, EA6, isolated from a hot water extract of an edible mushroom, Flammulina velutipes (Curt. ex Fr.) Sing., was investigated in sarcoma 180 bearing ICR mice. Oral administration (p.o.) of the EA6 stimulated anti-sheep red blood cells (SRBC) IgM antibody-producing activity of the spleen cells, and also delayed hypersensitivity (DTH) against SRBC in swelling of the foot pads of the tumor-bearing hosts. When EA6 p.o. was combined with cryosurgery, further augmentation of IgM-producing activity and DTH reaction to SRBC was recognized as compared with the EA6 single use. But the reticuloendothelial system of the mice, estimated by carbon clearance test, was not activated by EA6 p.o. or combined with cryosurgery.


Subject(s)
Antigens, Fungal/administration & dosage , Cryosurgery , Polysaccharides/therapeutic use , Sarcoma 180/immunology , Agaricales/immunology , Animals , Antibodies, Neoplasm/biosynthesis , Female , Hypersensitivity, Delayed/immunology , Immunity/drug effects , Immunoglobulin M/biosynthesis , Lymphocytes/metabolism , Mice , Mice, Inbred ICR , Mitogens/pharmacology , Phagocytosis/drug effects , Sarcoma 180/surgery , Thymidine/metabolism
4.
J Pharmacobiodyn ; 5(6): 439-44, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6889646

ABSTRACT

Augmentation of antitumor activity by combined in situ freeze-destruction of tumor (cryosurgery) and administration of antitumor active substances isolated from a hot water extract of an edible mushroom, Flammulina velutipes (Curt. ex Fr.) SING., was investigated in sarcoma 180 bearing ICR mice. Antitumor active substances of the mushroom included beta-(1,3)-glucan (EA3) and protein-bound polysaccharide (EA6). Antitumor activity was evaluated by the growth rate of the solid tumor rechallenged subcutaneously (s.c.) or by cumulative mortalities of the mice rechallenged intraperitoneally (i.p.) with the ascites tumor, on day 7 after cryosurgery. Weak antitumor effect induced by cryosurgery against challenged solid tumor of sarcoma 180 was markedly augmented by i.p. administration of EA6 (10 mg/kg). Cryosurgery of the solid sarcoma 180 apparently did not induce any antitumor effect against challenged ascites sarcoma 180. However, when cryosurgery was combined with oral administration of the polysaccharides (50 mg/kg), prolonged survival of the mice challenged with ascites sarcoma 180 i.p. was recognized by EA6, but not by EA3. Timing of the administration of EA6 (i.p.) with cryosurgery was best in pre- and post-cryosurgery. Immunological activity of EA6 to the host was discussed.


Subject(s)
Antineoplastic Agents/therapeutic use , Polysaccharides/therapeutic use , Proteoglycans/therapeutic use , Sarcoma 180/therapy , Agaricales , Animals , Carcinoma, Ehrlich Tumor/drug therapy , Carcinoma, Ehrlich Tumor/surgery , Carcinoma, Ehrlich Tumor/therapy , Cryosurgery , Female , Mice , Mice, Inbred ICR , Neoplasm Transplantation , Sarcoma 180/drug therapy , Sarcoma 180/surgery , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...